|
Expertise
Multum and its parent company, Cerner
Corporation, are healthcare information companies - not publishers. All of
Multum’s content is developed in-house by our full-time staff of physicians,
pharmacists, and software engineers, whose collective expertise creates products
that contain the most current and comprehensive drug information possible.
Multum's staff of software development engineers creates and maintains our
internal systems for content authorship and production.
Our researchers rely primarily on analysis of
primary medical literature. They also review secondary sources that include
manufacturer’s package labeling as well as prominent review articles, textbook
sources and FDA announcements. Our drug lexographers also use electronic links
to drug wholesalers and manufacturers for such information as new drug products,
proprietary names, and pricing.
Multum’s drug information is not licensed from any other source. As a result,
our products maintain a degree of internal consistency attained by few other drug information
vendors.
External Review
All clinical information generated in-house is
distributed to clinical experts from Multum’s independent
staff of medical reviewers. The reviewers are practicing clinicians
representing all major medical and surgical disciplines involved in
pharmacotherapy. Information is distributed to reviewers electronically on a
closed web-based network that allows rapid and collaborative review of clinical
topics before release of new information to our clients.
Patented Patient - Specific
Methodology
Multum is the only organization that can
provide patient specific dosing modules based on individual patient
characteristics. We own patents to the methodology used to derive patient
specific dosing and ordering based on characteristics such as age, height,
weight, liver function, and kidney function.
|